BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8645375)

  • 21. [DNA polymorphism in the region of APOB100, APOCIII, APOE, and angiotensin-converting enzyme genes and indicators of the lipid spectrum in children and adolescents in St. Petersburg].
    Skobeleva NA; Vasina VI; Volkova MV; Sverdlova AM; Fomicheva EV; Obraztsova GI; Talalaeva EI; Shakir Kh; Laasri M; Vorontsov IM; Kovalev IuP; Shvarts EI
    Mol Gen Mikrobiol Virusol; 1997; (4):36-40. PubMed ID: 9411220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HDL cholesterol levels in patients with molecularly defined familial hypercholesterolemia.
    Miltiadous G; Cariolou MA; Elisaf M
    Ann Clin Lab Sci; 2002; 32(1):50-4. PubMed ID: 11848618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of a novel exon 4 low-density lipoprotein receptor gene deletion in a swiss family with severe familial hypercholesterolemia.
    Neff D; Ruschitzka F; Hersberger M; Enseleit F; Hürlimann D; Noll G; Lüscher T; Hänseler E
    Clin Chem Lab Med; 2003 Mar; 41(3):266-71. PubMed ID: 12705331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic causes of familial hypercholesterolaemia in a Malaysian population.
    Khoo KL; Van Acker P; Tan H; Deslypere JP
    Med J Malaysia; 2000 Dec; 55(4):409-18. PubMed ID: 11221151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE.
    Jarauta E; Pérez-Ruiz MR; Pérez-Calahorra S; Mateo-Gallego R; Cenarro A; Cofán M; Ros E; Civeira F; Tejedor MT
    J Clin Lipidol; 2016; 10(6):1397-1405.e2. PubMed ID: 27919357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of apolipoprotein E genotypes on plasma lipid and lipoprotein concentrations: results from a segregation analysis in pedigrees with molecularly defined familial hypercholesterolemia.
    Friedlander Y; Leitersdorf E
    Genet Epidemiol; 1996; 13(2):159-77. PubMed ID: 8722744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia.
    Thiart R; Scholtz CL; Vergotine J; Hoogendijk CF; de Villiers JN; Nissen H; Brusgaard K; Gaffney D; Hoffs MS; Vermaak WJ; Kotze MJ
    J Med Genet; 2000 Jul; 37(7):514-9. PubMed ID: 10882754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of apolipoprotein E genotype on lipid levels and response to diet in familial hypercholesterolemia.
    Carmena-Ramón R; Real JT; Ascaso JF; Ordovás JM; Carmena R
    Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):7-13. PubMed ID: 10812582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G; Dobmeyer J; Nissen H; Hansen TS
    Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five polymorphisms in gene candidates for cardiovascular disease in Afro-Brazilian individuals.
    Sakuma T; Hirata RD; Hirata MH
    J Clin Lab Anal; 2004; 18(6):309-16. PubMed ID: 15543563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel functional APOB mutations outside LDL-binding region causing familial hypercholesterolaemia.
    Alves AC; Etxebarria A; Soutar AK; Martin C; Bourbon M
    Hum Mol Genet; 2014 Apr; 23(7):1817-28. PubMed ID: 24234650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study.
    Pek SLT; Dissanayake S; Fong JCW; Lin MX; Chan EZL; Tang JI; Lee CW; Ong HY; Sum CF; Lim SC; Tavintharan S
    Atherosclerosis; 2018 Feb; 269():106-116. PubMed ID: 29353225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of the apolipoprotein E polymorphism on lipid levels in patients with familial defective apolipoprotein B-100.
    Manke C; Schuster H; Keller C; Wolfram G
    Clin Investig; 1993 Apr; 71(4):277-80. PubMed ID: 8471813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutation.
    Civeira F; Castillo S; Alonso R; Meriño-Ibarra E; Cenarro A; Artied M; Martín-Fuentes P; Ros E; Pocoví M; Mata P;
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1960-5. PubMed ID: 16020744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E polymorphism is not associated with lipid levels and coronary artery disease in Greek patients with familial hypercholesterolaemia.
    Pitsavos C; Choumerianou DM; Skoumas J; Maumus S; Stefanadis C; Dedoussis GV; Visvikis-Siest S
    Clin Exp Med; 2005 Dec; 5(4):196-201. PubMed ID: 16362800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
    Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
    Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece.
    Diakou M; Miltiadous G; Xenophontos SL; Manoli P; Cariolou MA; Elisaf M
    Eur J Intern Med; 2011 Oct; 22(5):e55-9. PubMed ID: 21925044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular genetics of familial hypercholesterolaemia in Norway.
    Leren TP; Tonstad S; Gundersen KE; Bakken KS; Rødningen OK; Sundvold H; Ose L; Berg K
    J Intern Med; 1997 Mar; 241(3):185-94. PubMed ID: 9104431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.